“Korea has low new drug access. It needs to be improved.”

As much as the phrase comes to heart, we need to look more closely into the matter to correctly assess the situation.

Recently, the Korean Research-based Pharmaceutical Industry Association (KRPIA) recently published a report on Korea’s current new drug release status based on the ‘Global Access to New Medicines Report.’

The Global Access to New Medicines Report was published by the ‘Pharmaceutical Research and Manufacturers of America (PhRMA)’ in April. The report investigated new drug release and health insurance reimbursement status in a total of 72 countries including Korea, and subdivided the investigat